25 XP   0   0   10

Fisher & Paykel Healthcare Corporation Limited
Buy, Hold or Sell?

Let's analyse Fisher & Paykel Healthcare Corporation Limited together

PenkeI guess you are interested in Fisher & Paykel Healthcare Corporation Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fisher & Paykel Healthcare Corporation Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Fisher & Paykel Healthcare Corporation Limited

I send you an email if I find something interesting about Fisher & Paykel Healthcare Corporation Limited.

Quick analysis of Fisher & Paykel Healthcare Corporation Limited (30 sec.)










What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited? (30 sec.)

How much money do you get?

How much money do you get?
$0.83
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$1.85
Expected worth in 1 year
$2.17
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$1.14
Return On Investment
6.9%

For what price can you sell your share?

Current Price per Share
$16.43
Expected price per share
$16.14 - $16.14
How sure are you?
50%

1. Valuation of Fisher & Paykel Healthcare Corporation Limited (5 min.)




Live pricePrice per Share (EOD)

$16.43

Intrinsic Value Per Share

$-2.35 - $-0.99

Total Value Per Share

$-0.49 - $0.87

2. Growth of Fisher & Paykel Healthcare Corporation Limited (5 min.)




Is Fisher & Paykel Healthcare Corporation Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$1b$45.3m4.2%

How much money is Fisher & Paykel Healthcare Corporation Limited making?

Current yearPrevious yearGrowGrow %
Making money$154m$232m-$77.9m-50.6%
Net Profit Margin15.8%22.9%--

How much money comes from the company's main activities?

3. Financial Health of Fisher & Paykel Healthcare Corporation Limited (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#47 / 168

Most Revenue
#21 / 168

Most Profit
#15 / 168

What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited? (5 min.)

Welcome investor! Fisher & Paykel Healthcare Corporation Limited's management wants to use your money to grow the business. In return you get a share of Fisher & Paykel Healthcare Corporation Limited.

What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited?

First you should know what it really means to hold a share of Fisher & Paykel Healthcare Corporation Limited. And how you can make/lose money.

Speculation

The Price per Share of Fisher & Paykel Healthcare Corporation Limited is $16.43. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fisher & Paykel Healthcare Corporation Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fisher & Paykel Healthcare Corporation Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.85. Based on the TTM, the Book Value Change Per Share is $0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.21 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fisher & Paykel Healthcare Corporation Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.261.6%0.261.6%0.402.4%0.352.1%0.251.5%
Usd Book Value Change Per Share0.080.5%0.080.5%0.171.0%0.211.3%0.150.9%
Usd Dividend Per Share0.211.3%0.211.3%0.241.4%0.181.1%0.130.8%
Usd Total Gains Per Share0.281.7%0.281.7%0.412.5%0.392.4%0.281.7%
Usd Price Per Share15.22-15.22-16.26-16.53-10.51-
Price to Earnings Ratio57.50-57.50-40.80-49.26-37.24-
Price-to-Total Gains Ratio53.43-53.43-40.08-48.64-45.12-
Price to Book Ratio8.21-8.21-9.15-11.98-9.23-
Price-to-Total Gains Ratio53.43-53.43-40.08-48.64-45.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share16.43
Number of shares60
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.210.18
Usd Book Value Change Per Share0.080.21
Usd Total Gains Per Share0.280.39
Gains per Quarter (60 shares)17.0923.54
Gains per Year (60 shares)68.3794.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1501958445084
2993712688101178
314956194131151272
419975262175201366
524894330219252460
6298112398263302554
7348131466307352648
8397150534350403742
9447168602394453836
10497187670438504930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.03.00.087.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.01.00.095.8%

Fundamentals of Fisher & Paykel Healthcare Corporation Limited

About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Fundamental data was last updated by Penke on 2024-05-16 15:18:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Fisher & Paykel Healthcare Corporation Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fisher & Paykel Healthcare Corporation Limited earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 15.8% means that $0.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 15.8%. The company is making a huge profit. +2
  • The TTM is 15.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.8%TTM15.8%0.0%
TTM15.8%YOY22.9%-7.2%
TTM15.8%5Y21.5%-5.8%
5Y21.5%10Y19.9%+1.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ15.8%5.3%+10.5%
TTM15.8%5.9%+9.9%
YOY22.9%5.1%+17.8%
5Y21.5%7.0%+14.5%
10Y19.9%6.7%+13.2%
1.1.2. Return on Assets

Shows how efficient Fisher & Paykel Healthcare Corporation Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • 11.4% Return on Assets means that Fisher & Paykel Healthcare Corporation Limited generated $0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 11.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 11.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ11.4%TTM11.4%0.0%
TTM11.4%YOY17.9%-6.5%
TTM11.4%5Y18.4%-7.0%
5Y18.4%10Y18.1%+0.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4%0.7%+10.7%
TTM11.4%0.9%+10.5%
YOY17.9%1.4%+16.5%
5Y18.4%1.5%+16.9%
10Y18.1%1.5%+16.6%
1.1.3. Return on Equity

Shows how efficient Fisher & Paykel Healthcare Corporation Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • 14.3% Return on Equity means Fisher & Paykel Healthcare Corporation Limited generated $0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 14.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.3%TTM14.3%0.0%
TTM14.3%YOY22.4%-8.2%
TTM14.3%5Y24.7%-10.4%
5Y24.7%10Y24.9%-0.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%1.5%+12.8%
TTM14.3%1.8%+12.5%
YOY22.4%2.7%+19.7%
5Y24.7%3.0%+21.7%
10Y24.9%2.8%+22.1%

1.2. Operating Efficiency of Fisher & Paykel Healthcare Corporation Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fisher & Paykel Healthcare Corporation Limited is operating .

  • Measures how much profit Fisher & Paykel Healthcare Corporation Limited makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 21.1% means the company generated $0.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 21.1%. The company is operating efficient. +1
  • The TTM is 21.1%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.1%TTM21.1%0.0%
TTM21.1%YOY31.0%-9.9%
TTM21.1%5Y30.0%-8.9%
5Y30.0%10Y30.7%-0.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ21.1%7.4%+13.7%
TTM21.1%4.6%+16.5%
YOY31.0%9.3%+21.7%
5Y30.0%9.5%+20.5%
10Y30.7%9.0%+21.7%
1.2.2. Operating Ratio

Measures how efficient Fisher & Paykel Healthcare Corporation Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.85 means that the operating costs are $0.85 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.848. The company is less efficient in keeping operating costs low.
  • The TTM is 0.848. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.848TTM0.8480.000
TTM0.848YOY0.775+0.074
TTM0.8485Y0.765+0.084
5Y0.76510Y0.794-0.029
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8481.111-0.263
TTM0.8481.124-0.276
YOY0.7751.149-0.374
5Y0.7651.110-0.345
10Y0.7941.051-0.257

1.3. Liquidity of Fisher & Paykel Healthcare Corporation Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.67 means the company has $2.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 2.671. The company is able to pay all its short-term debts. +1
  • The TTM is 2.671. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.671TTM2.6710.000
TTM2.671YOY2.922-0.250
TTM2.6715Y2.353+0.319
5Y2.35310Y2.235+0.118
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6712.311+0.360
TTM2.6712.401+0.270
YOY2.9222.556+0.366
5Y2.3532.672-0.319
10Y2.2352.619-0.384
1.3.2. Quick Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.17 means the company can pay off $1.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 1.173. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.173. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.173TTM1.1730.000
TTM1.173YOY2.186-1.013
TTM1.1735Y1.774-0.601
5Y1.77410Y1.582+0.192
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1731.064+0.109
TTM1.1731.064+0.109
YOY2.1861.231+0.955
5Y1.7741.369+0.405
10Y1.5821.553+0.029

1.4. Solvency of Fisher & Paykel Healthcare Corporation Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fisher & Paykel Healthcare Corporation Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.20 means that Fisher & Paykel Healthcare Corporation Limited assets are financed with 20.5% credit (debt) and the remaining percentage (100% - 20.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.205. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.205. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.205TTM0.2050.000
TTM0.205YOY0.203+0.002
TTM0.2055Y0.248-0.043
5Y0.24810Y0.269-0.021
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2050.348-0.143
TTM0.2050.356-0.151
YOY0.2030.343-0.140
5Y0.2480.361-0.113
10Y0.2690.365-0.096
1.4.2. Debt to Equity Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 25.7% means that company has $0.26 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.257. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.257. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.257TTM0.2570.000
TTM0.257YOY0.254+0.003
TTM0.2575Y0.334-0.077
5Y0.33410Y0.373-0.039
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2570.521-0.264
TTM0.2570.546-0.289
YOY0.2540.500-0.246
5Y0.3340.611-0.277
10Y0.3730.642-0.269

2. Market Valuation of Fisher & Paykel Healthcare Corporation Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Fisher & Paykel Healthcare Corporation Limited generates.

  • Above 15 is considered overpriced but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 57.50 means the investor is paying $57.50 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 62.077. Based on the earnings, the company is expensive. -2
  • The MRQ is 57.505. Based on the earnings, the company is expensive. -2
  • The TTM is 57.505. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD62.077MRQ57.505+4.572
MRQ57.505TTM57.5050.000
TTM57.505YOY40.799+16.706
TTM57.5055Y49.263+8.242
5Y49.26310Y37.242+12.021
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD62.07717.121+44.956
MRQ57.50516.169+41.336
TTM57.50516.130+41.375
YOY40.79921.198+19.601
5Y49.26320.998+28.265
10Y37.24227.674+9.568
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is -73.534. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -68.119. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -68.119. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-73.534MRQ-68.119-5.415
MRQ-68.119TTM-68.1190.000
TTM-68.119YOY-90.560+22.441
TTM-68.1195Y-58.294-9.825
5Y-58.29410Y-22.800-35.494
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-73.534-1.121-72.413
MRQ-68.119-1.779-66.340
TTM-68.1192.017-70.136
YOY-90.5604.353-94.913
5Y-58.2947.535-65.829
10Y-22.8000.417-23.217
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fisher & Paykel Healthcare Corporation Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 8.21 means the investor is paying $8.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 8.862. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.209. Based on the equity, the company is overpriced. -1
  • The TTM is 8.209. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.862MRQ8.209+0.653
MRQ8.209TTM8.2090.000
TTM8.209YOY9.155-0.946
TTM8.2095Y11.980-3.772
5Y11.98010Y9.227+2.753
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD8.8622.758+6.104
MRQ8.2092.732+5.477
TTM8.2092.691+5.518
YOY9.1552.970+6.185
5Y11.9804.092+7.888
10Y9.2274.408+4.819
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Fisher & Paykel Healthcare Corporation Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0780.0780%0.168-54%0.210-63%0.146-47%
Book Value Per Share--1.8541.8540%1.776+4%1.447+28%1.024+81%
Current Ratio--2.6712.6710%2.922-9%2.353+14%2.235+20%
Debt To Asset Ratio--0.2050.2050%0.203+1%0.248-17%0.269-24%
Debt To Equity Ratio--0.2570.2570%0.254+1%0.334-23%0.373-31%
Dividend Per Share--0.2070.2070%0.238-13%0.182+13%0.131+57%
Eps--0.2650.2650%0.399-34%0.349-24%0.250+6%
Free Cash Flow Per Share---0.223-0.2230%-0.180-20%-0.130-42%-0.040-82%
Free Cash Flow To Equity Per Share---0.432-0.4320%-0.429-1%-0.319-26%-0.177-59%
Gross Profit Margin---0.726-0.7260%-0.043-94%-0.254-65%-0.444-39%
Intrinsic Value_10Y_max---0.985--------
Intrinsic Value_10Y_min---2.348--------
Intrinsic Value_1Y_max---0.053--------
Intrinsic Value_1Y_min---0.211--------
Intrinsic Value_3Y_max---0.194--------
Intrinsic Value_3Y_min---0.658--------
Intrinsic Value_5Y_max---0.377--------
Intrinsic Value_5Y_min---1.129--------
Market Cap9565052837.120+7%8860627156.4808860627156.4800%9466083939.840-6%9624445818.888-8%6115701503.620+45%
Net Profit Margin--0.1580.1580%0.229-31%0.215-27%0.199-21%
Operating Margin--0.2110.2110%0.310-32%0.300-30%0.307-31%
Operating Ratio--0.8480.8480%0.775+10%0.765+11%0.794+7%
Pb Ratio8.862+7%8.2098.2090%9.155-10%11.980-31%9.227-11%
Pe Ratio62.077+7%57.50557.5050%40.799+41%49.263+17%37.242+54%
Price Per Share16.430+7%15.22015.2200%16.260-6%16.532-8%10.505+45%
Price To Free Cash Flow Ratio-73.534-8%-68.119-68.1190%-90.560+33%-58.294-14%-22.800-67%
Price To Total Gains Ratio57.675+7%53.42853.4280%40.076+33%48.636+10%45.125+18%
Quick Ratio--1.1731.1730%2.186-46%1.774-34%1.582-26%
Return On Assets--0.1140.1140%0.179-37%0.184-38%0.181-37%
Return On Equity--0.1430.1430%0.224-36%0.247-42%0.249-43%
Total Gains Per Share--0.2850.2850%0.406-30%0.392-27%0.277+3%
Usd Book Value--1079393040.0001079393040.0000%1034023320.000+4%842263920.000+28%596085849.360+81%
Usd Book Value Change Per Share--0.0780.0780%0.168-54%0.210-63%0.146-47%
Usd Book Value Per Share--1.8541.8540%1.776+4%1.447+28%1.024+81%
Usd Dividend Per Share--0.2070.2070%0.238-13%0.182+13%0.131+57%
Usd Eps--0.2650.2650%0.399-34%0.349-24%0.250+6%
Usd Free Cash Flow---130076280.000-130076280.0000%-104528880.000-20%-75903480.000-42%-23436476.619-82%
Usd Free Cash Flow Per Share---0.223-0.2230%-0.180-20%-0.130-42%-0.040-82%
Usd Free Cash Flow To Equity Per Share---0.432-0.4320%-0.429-1%-0.319-26%-0.177-59%
Usd Market Cap9565052837.120+7%8860627156.4808860627156.4800%9466083939.840-6%9624445818.888-8%6115701503.620+45%
Usd Price Per Share16.430+7%15.22015.2200%16.260-6%16.532-8%10.505+45%
Usd Profit--154084680.000154084680.0000%232019640.000-34%202889448.000-24%145337188.680+6%
Usd Revenue--977942160.000977942160.0000%1011061440.000-3%926441064.000+6%701156888.280+39%
Usd Total Gains Per Share--0.2850.2850%0.406-30%0.392-27%0.277+3%
 EOD+5 -3MRQTTM+0 -0YOY+6 -305Y+13 -2310Y+20 -16

3.2. Fundamental Score

Let's check the fundamental score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1562.077
Price to Book Ratio (EOD)Between0-18.862
Net Profit Margin (MRQ)Greater than00.158
Operating Margin (MRQ)Greater than00.211
Quick Ratio (MRQ)Greater than11.173
Current Ratio (MRQ)Greater than12.671
Debt to Asset Ratio (MRQ)Less than10.205
Debt to Equity Ratio (MRQ)Less than10.257
Return on Equity (MRQ)Greater than0.150.143
Return on Assets (MRQ)Greater than0.050.114
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose16.430
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in NZD. All numbers in thousands.

Summary
Total Assets2,204,500
Total Liabilities451,100
Total Stockholder Equity1,753,400
 As reported
Total Liabilities 451,100
Total Stockholder Equity+ 1,753,400
Total Assets = 2,204,500

Assets

Total Assets2,204,500
Total Current Assets774,200
Long-term Assets1,430,300
Total Current Assets
Cash And Cash Equivalents 121,000
Short-term Investments 468
Net Receivables 218,500
Inventory 365,800
Other Current Assets 68,900
Total Current Assets  (as reported)774,200
Total Current Assets  (calculated)774,668
+/- 468
Long-term Assets
Property Plant Equipment 1,148,200
Intangible Assets 85,600
Other Assets 196,200
Long-term Assets  (as reported)1,430,300
Long-term Assets  (calculated)1,430,000
+/- 300

Liabilities & Shareholders' Equity

Total Current Liabilities289,800
Long-term Liabilities161,300
Total Stockholder Equity1,753,400
Total Current Liabilities
Short-term Debt 21,300
Short Long Term Debt 4,200
Accounts payable 43,000
Other Current Liabilities 225,500
Total Current Liabilities  (as reported)289,800
Total Current Liabilities  (calculated)294,000
+/- 4,200
Long-term Liabilities
Long term Debt 79,100
Capital Lease Obligations Min Short Term Debt41,200
Other Liabilities 36,800
Long-term Liabilities  (as reported)161,300
Long-term Liabilities  (calculated)157,100
+/- 4,200
Total Stockholder Equity
Common Stock303,700
Retained Earnings 1,200,500
Other Stockholders Equity 249,200
Total Stockholder Equity (as reported)1,753,400
Total Stockholder Equity (calculated)1,753,400
+/-0
Other
Capital Stock303,700
Cash and Short Term Investments 121,000
Common Stock Shares Outstanding 581,631
Liabilities and Stockholders Equity 2,204,500
Net Debt 24,800
Net Invested Capital 1,836,700
Net Tangible Assets 1,667,800
Net Working Capital 484,400
Property Plant and Equipment Gross 1,632,600
Short Long Term Debt Total 145,800



Balance Sheet

Currency in NZD. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-31
> Total Assets 
459,219
236,686
215,333
228,752
224,173
230,310
267,470
274,667
331,667
413,737
475,059
517,608
572,054
618,597
630,325
669,816
766,803
878,191
1,025,100
1,206,700
1,435,000
2,075,000
2,107,000
2,204,500
2,204,5002,107,0002,075,0001,435,0001,206,7001,025,100878,191766,803669,816630,325618,597572,054517,608475,059413,737331,667274,667267,470230,310224,173228,752215,333236,686459,219
   > Total Current Assets 
221,164
163,137
140,582
133,773
122,521
127,658
125,339
118,180
129,574
172,675
180,065
186,487
195,031
215,157
234,958
243,291
285,720
349,084
424,200
455,300
518,700
920,000
887,900
774,200
774,200887,900920,000518,700455,300424,200349,084285,720243,291234,958215,157195,031186,487180,065172,675129,574118,180125,339127,658122,521133,773140,582163,137221,164
       Cash And Cash Equivalents 
2,622
102,174
73,310
13,336
30,578
23,057
16,554
7,742
5,263
5,465
6,891
6,110
6,253
7,709
10,438
13,621
18,741
61,251
31,900
48,200
67,100
97,300
89,900
121,000
121,00089,90097,30067,10048,20031,90061,25118,74113,62110,4387,7096,2536,1106,8915,4655,2637,74216,55423,05730,57813,33673,310102,1742,622
       Short-term Investments 
0
0
0
35,000
17,000
14,000
12,000
0
2,865
6,256
21,443
14,871
21,050
28,360
33,141
23,776
11,524
19,330
100,400
92,500
77,700
280,300
200,000
468
468200,000280,30077,70092,500100,40019,33011,52423,77633,14128,36021,05014,87121,4436,2562,865012,00014,00017,00035,000000
       Net Receivables 
90,789
34,100
41,752
58,996
49,143
54,585
55,367
58,452
60,262
80,996
71,437
79,622
77,130
81,560
93,363
107,416
131,361
129,642
146,000
157,900
222,700
222,500
174,400
218,500
218,500174,400222,500222,700157,900146,000129,642131,361107,41693,36381,56077,13079,62271,43780,99660,26258,45255,36754,58549,14358,99641,75234,10090,789
       Inventory 
72,907
18,270
19,216
21,852
24,076
30,906
36,190
46,697
50,770
69,946
71,763
80,101
84,430
89,111
94,475
96,143
120,948
134,982
125,400
136,100
146,500
270,600
358,900
365,800
365,800358,900270,600146,500136,100125,400134,982120,94896,14394,47589,11184,43080,10171,76369,94650,77046,69736,19030,90624,07621,85219,21618,27072,907
       Other Current Assets 
54,846
8,593
6,304
4,589
316
500
4,468
5,289
8,625
7,195
1,784
281
399
1,147
1,266
1,835
1,692
1,866
20,500
20,600
4,700
49,300
64,700
68,900
68,90064,70049,3004,70020,60020,5001,8661,6921,8351,2661,1473992811,7847,1958,6255,2894,4685003164,5896,3048,59354,846
   > Long-term Assets 
0
73,549
74,751
94,979
101,652
102,652
142,131
156,487
202,093
241,062
294,994
331,121
377,023
403,440
395,367
426,525
481,083
529,107
600,900
751,400
916,300
1,155,000
1,219,100
1,430,300
1,430,3001,219,1001,155,000916,300751,400600,900529,107481,083426,525395,367403,440377,023331,121294,994241,062202,093156,487142,131102,652101,65294,97974,75173,5490
       Property Plant Equipment 
177,667
58,914
64,917
71,448
71,545
82,899
128,296
141,885
186,489
204,558
233,278
254,265
311,631
346,716
349,760
367,428
389,609
425,160
476,400
601,400
735,300
882,100
957,800
1,148,200
1,148,200957,800882,100735,300601,400476,400425,160389,609367,428349,760346,716311,631254,265233,278204,558186,489141,885128,29682,89971,54571,44864,91758,914177,667
       Goodwill 
1,657
2,955
1,133
2,185
1,800
1,415
1,030
645
1,030
1,030
1,030
1,030
1,030
1,450
1,450
1,450
0
0
0
0
0
0
0
0
000000001,4501,4501,4501,0301,0301,0301,0301,0306451,0301,4151,8002,1851,1332,9551,657
       Long Term Investments 
56,740
45,568
-889
0
0
0
0
0
0
0
0
0
0
0
777
17
10
22,059
900
400
0
0
0
0
000040090022,059101777700000000000-88945,56856,740
       Intangible Assets 
0
0
2,570
3,949
4,032
2,382
2,255
2,231
4,287
4,469
4,891
5,390
5,396
7,176
8,955
20,980
35,757
44,475
50,400
61,500
73,900
80,000
86,800
85,600
85,60086,80080,00073,90061,50050,40044,47535,75720,9808,9557,1765,3965,3904,8914,4694,2872,2312,2552,3824,0323,9492,57000
       Long-term Assets Other 
0
11,680
4,135
11,827
12,370
2,774
261
1,388
2,284
8,323
23,132
17,709
23,756
17,185
6,607
7,255
14,171
9,127
39,400
49,600
0
111,600
90,900
99,900
99,90090,900111,600049,60039,4009,12714,1717,2556,60717,18523,75617,70923,1328,3232,2841,3882612,77412,37011,8274,13511,6800
> Total Liabilities 
267,796
84,592
43,450
35,935
32,948
38,279
63,477
81,153
136,003
209,436
181,895
204,317
223,902
246,366
224,203
198,626
225,134
216,566
263,700
293,500
461,200
554,100
427,300
451,100
451,100427,300554,100461,200293,500263,700216,566225,134198,626224,203246,366223,902204,317181,895209,436136,00381,15363,47738,27932,94835,93543,45084,592267,796
   > Total Current Liabilities 
152,655
62,702
41,760
34,766
30,433
37,356
62,341
80,117
110,381
93,854
97,812
84,178
150,623
91,068
128,790
117,114
149,523
145,580
178,400
184,400
334,600
427,500
303,900
289,800
289,800303,900427,500334,600184,400178,400145,580149,523117,114128,79091,068150,62384,17897,81293,854110,38180,11762,34137,35630,43334,76641,76062,702152,655
       Short-term Debt 
94,465
8,586
7,454
3,106
6,326
8,065
23,841
40,845
65,007
23,447
24,502
17,110
80,230
17,136
45,786
14,154
16,286
21,091
29,900
17,300
92,200
26,600
17,000
21,300
21,30017,00026,60092,20017,30029,90021,09116,28614,15445,78617,13680,23017,11024,50223,44765,00740,84523,8418,0656,3263,1067,4548,58694,465
       Short Long Term Debt 
94,465
77,052
2,727
0
0
0
0
0
0
0
0
0
0
0
112,740
1,374
2,105
21,091
29,900
17,300
80,600
11,900
5,300
4,200
4,2005,30011,90080,60017,30029,90021,0912,1051,374112,740000000000002,72777,05294,465
       Accounts payable 
26,468
8,496
8,367
8,677
10,810
15,075
19,173
15,907
14,660
23,677
22,812
21,117
22,506
21,139
23,221
27,663
36,963
29,320
32,700
55,100
69,300
56,700
53,800
43,000
43,00053,80056,70069,30055,10032,70029,32036,96327,66323,22121,13922,50621,11722,81223,67714,66015,90719,17315,07510,8108,6778,3678,49626,468
       Other Current Liabilities 
31,722
45,620
25,939
22,983
13,297
14,216
19,327
23,365
30,714
46,730
50,498
45,951
47,887
52,793
59,783
75,297
96,274
95,169
115,800
112,000
173,100
344,200
233,100
225,500
225,500233,100344,200173,100112,000115,80095,16996,27475,29759,78352,79347,88745,95150,49846,73030,71423,36519,32714,21613,29722,98325,93945,62031,722
   > Long-term Liabilities 
0
21,890
1,690
1,169
2,515
923
1,136
1,036
25,622
115,582
84,083
120,139
73,279
155,298
95,413
81,512
75,611
70,986
85,300
109,100
126,600
126,600
123,400
161,300
161,300123,400126,600126,600109,10085,30070,98675,61181,51295,413155,29873,279120,13984,083115,58225,6221,0361,1369232,5151,1691,69021,8900
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,600
43,700
36,000
62,500
62,50036,00043,70033,60000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,297
0
0
0
0
0
0
00000014,29700000000000000000
> Total Stockholder Equity
191,423
152,094
171,883
192,817
191,225
192,031
203,993
193,514
195,664
204,301
293,164
313,291
348,152
372,231
406,122
471,190
541,669
661,625
761,400
913,200
973,800
1,520,900
1,679,700
1,753,400
1,753,4001,679,7001,520,900973,800913,200761,400661,625541,669471,190406,122372,231348,152313,291293,164204,301195,664193,514203,993192,031191,225192,817171,883152,094191,423
   Common Stock
0
152,094
171,883
172,724
170,607
192,031
203,993
193,514
3,647
4,076
13,000
38,719
63,305
91,280
120,373
145,871
163,244
181,830
198,400
219,200
225,400
249,100
261,200
303,700
303,700261,200249,100225,400219,200198,400181,830163,244145,871120,37391,28063,30538,71913,0004,0763,647193,514203,993192,031170,607172,724171,883152,0940
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-2,021
-3,951
-3,591
-246
0
3,349
12,499
84,103
89,852
100,821
86,033
61,238
58,548
50,571
88,759
95,700
144,800
62,100
242,600
237,300
249,200
249,200237,300242,60062,100144,80095,70088,75950,57158,54861,23886,033100,82189,85284,10312,4993,3490-246-3,591-3,951-2,021000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
-171,883
2,021
3,951
3,591
246
0
0
0
0
0
0
0
61,238
58,548
50,571
88,800
95,700
144,800
62,100
242,600
237,300
249,200
249,200237,300242,60062,100144,80095,70088,80050,57158,54861,23800000002463,5913,9512,021-171,88300



Balance Sheet

Currency in NZD. All numbers in thousands.




Cash Flow

Currency in NZD. All numbers in thousands.




Income Statement

Currency in NZD. All numbers in thousands.